SOD1 and amyotrophic lateral sclerosis: Despite the variability reported in human studies, it has been shown that the ALS disease severity can be directly manipulated in antibiotic-treated SOD1-G93A mice by supplementing these animals with certain gut microbial species [144], highlighting the potential effect of gut metabolites on neural function.